Patents by Inventor Sarah Anne Welsby

Sarah Anne Welsby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and treatment of wound infection with procalcitonin as diagnostic marker
    Patent number: 10739352
    Abstract: A method of diagnosis or prediction of infection of a mammalian wound, said method comprising the step of detecting the presence of a cytokine selected from the group comprising procalcitonin, amino procalcitonin (N-ProCT), eotaxin, granulocyte macrophage colony stimulating factor (GM-CSF), interleukins IB monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 alpha (MIP-1a), regulated upon activation normal T expressed and secreted (RANTES) in fluid taken from the wound. Also claimed is the device for use in the method.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: August 11, 2020
    Assignee: CONVATEC TECHNOLOGIES INC.
    Inventors: Philip Godfrey Bowler, Samantha Alison Jones, Sarah Anne Welsby
  • DIAGNOSTIC MARKERS OF WOUND INFECTION
    Publication number: 20110039342
    Abstract: A method of diagnosis or prediction of infection of a mammalian wound, said method comprising the step of detecting the presence of a cytokine selected from the group comprising procalcitonin, amino procalcitonin (N-ProCT), eotaxin, granulocyte macrophage colony stimulating factor (GM-CSF), interleukins IB monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 alpha (MIP-1a), regulated upon activation normal T expressed and secreted (RANTES) in fluid taken from the wound. Also claimed is the device for use in the method.
    Type: Application
    Filed: November 20, 2008
    Publication date: February 17, 2011
    Applicant: Conva Tec Technologies Inc.
    Inventors: Steven Lane Percival, Philip Godfrey Bowler, Samantha Alison Jones, Sarah Anne Welsby